Interconnection between polycystic ovary syndrome, immune disorders, and reproductive outcomes.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and clinical literature without systematic review methodology
PubMed 41961878 · doi:10.1530/RAF-25-0186
What was done
This was a narrative review summarizing literature on immunological mechanisms in polycystic ovary syndrome (PCOS), focusing on systemic inflammation, ovarian and endometrial immune alterations, autoimmune features, adverse reproductive outcomes, and potential immunomodulatory effects of metabolic therapies.
What was found
The abstract provides no numerical data, sample sizes, or effect estimates. Qualitatively, it reports that PCOS is associated with elevated circulating inflammatory cytokines (IL-6, IL-1β, IL-18, TNF-α), macrophage and lymphocyte infiltration into ovarian and endometrial tissues, Th1/Th2 and Th17/Treg imbalances, autoantibodies (antinuclear, antithyroid, antiphospholipid), and higher co-occurrence of autoimmune conditions like Hashimoto's thyroiditis and type 1 diabetes.
Why it matters
The paper synthesizes evidence framing PCOS as an integrated immunometabolic disorder, highlighting pathways that may explain reproductive complications like implantation failure and recurrent pregnancy loss.
Limits
As a narrative review, it lacks a systematic search protocol, formal quality or risk of bias assessment, and quantitative meta-analytic pooling. The abstract reports no primary experimental data or quantitative estimates.
Cited by
- context Of the 20 to 30 percent of PCOS patients who ovulate, approximately 40 percent fail to form a viable embryo or achieve pregnancy due to impaired egg quality and suboptimal endometrial progesterone receptivity.